Actis G C, Ponzetto A, Rizzetto M, Verme G
Am J Dig Dis. 1978 Oct;23(10):883-6. doi: 10.1007/BF01072460.
To determine whether a sensitization to ethanol metabolites occurs in alcoholic liver disease, reactivity of lymphocytes to nontoxic amounts of acetaldehyde was studied by direct elaboration of migration inhibitory factor (MIF) production. Eighteen alcoholics with various degrees of biopsy-proven liver damage showed increased MIF production in response to acetaldehyde; the mean value of the group differed significantly from 15 healthy controls, 15 subjects with nonalcoholic liver disease, and 15 alcoholics without liver involvement (P less than 0.001, P less than 0.001, P less than 0.02, respectively). Among the alcoholics with liver disease, none individuals (50%) with histological signs of advanced alcoholic hepatitis showed the highest percentage of inhibition of migration; the value differed significantly from the remaining patients with lesser degrees of hyaline necrosis in liver biopsies (P less than 0.005). These results indicate that acetaldehyde is involved in the pathogenesis of alcoholic hepatitis. Clinically, this test might facilitate the selection of patients with alcoholic hyaline necrosis.
为了确定酒精性肝病中是否会出现对乙醇代谢产物的致敏作用,通过直接检测迁移抑制因子(MIF)的产生来研究淋巴细胞对无毒量乙醛的反应性。18例经活检证实有不同程度肝损伤的酗酒者,其淋巴细胞对乙醛反应后MIF产生增加;该组的平均值与15名健康对照者、15名非酒精性肝病患者以及15名无肝脏受累的酗酒者相比有显著差异(分别为P<0.001、P<0.001、P<0.02)。在患有肝病的酗酒者中,有严重酒精性肝炎组织学表现的个体(50%)迁移抑制率最高;该值与肝活检中透明样坏死程度较轻的其余患者有显著差异(P<0.005)。这些结果表明乙醛参与了酒精性肝炎的发病机制。临床上,这项检测可能有助于选择患有酒精性透明样坏死的患者。